Business News • PR NewsWire • Mylan and Zyomyx Enter into Exclusive Distribution Agreement for Innovative Point-of-Care CD4 Diagnostic Test, Enhancing Mylan's Leadership Position in HIV Care

Mylan and Zyomyx Enter into Exclusive Distribution Agreement for Innovative Point-of-Care CD4 Diagnostic Test, Enhancing Mylan's Leadership Position in HIV Care

Mylan and Zyomyx Enter into Exclusive Distribution Agreement for Innovative Point-of-Care CD4 Diagnostic Test, Enhancing Mylan's Leadership Position in HIV Care

PITTSBURGH and FREMONT, Calif., June 30, 2013 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that it has entered into an exclusive agreement with Zyomyx, Inc. for the rights to distribute Zyomyx's proprietary point-of-care (POC) CD4 T-cell count test in the developing...

View More : http://www.prnewswire.com/news-releases/mylan-and-zyomyx-enter-into-exclusive-distribution-agreement-for-innovative-poin...

Releted News by prnewswire

With Access to the Full, Customized TalkChart Solution, Physicians Can Experience the Real Power of Personalized EHR

Thamer Al-Hassan of Saudi Arabia was Awarded for his Photo of Emirates Second Prize in the PX3 2013 Competition and Bronze FIAP at Serbia

Standard Pacific Homes Brings Highly-Anticipated New Home Designs To Del Sur, San Diego's Premier Master-Planned Community

With Violent Crime on the Increase are you Concerned About the Safety of Yourself and Others?

Flora Hospitality Proudly Announces the Opening of its New Flora Al SOUQ Hotel in Dubai